Elisa A. Karlson is EVP & Chief Admin Officer at VALEANT PHARMACEUTICALS INTERNATIONAL (VRX). They have made 7 open-market trades across 1 company since 2008, most recently 2010-09-28.
CIK 0001435755
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $300K since 2008, never a sale. Across 7 scored buys the stock is up 0.4% at ninety days, and 0.2 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| VRX | 83,264 | $1.9M |
Shares reported on the most recent Form 4, priced at the 2010-04-07 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 100% | 100% |
| Avg Move | -12.8% | +0.4% | +0.4% |
| Alpha | -7.0% | +0.2% | +0.2% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRX | BUY | 2009-03-11 | 2009-03-12 | $16.97 | $90K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2008-07-03 | 2008-07-07 | $16.20 | $35K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2008-06-27 | 2008-06-27 | $17.08 | $35K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2008-06-20 | 2008-06-20 | $17.02 | $35K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2008-06-13 | 2008-06-16 | $16.83 | $35K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2008-06-06 | 2008-06-09 | $16.23 | $35K | -12.8% | +0.4% | +0.4% |
| VRX | BUY | 2008-05-30 | 2008-06-03 | $16.37 | $35K | -12.8% | +0.4% | +0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.